168 related articles for article (PubMed ID: 38783952)
21. Neutralization of
Rajesh KS; Bharath BR; Rao CV; Bhat KI; Bhat KSC; Bhat P
Toxicol Rep; 2017; 4():637-645. PubMed ID: 29234602
[No Abstract] [Full Text] [Related]
22. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.
Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ
Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174
[TBL] [Abstract][Full Text] [Related]
23. Remarkable intrapopulation venom variability in the monocellate cobra (Naja kaouthia) unveils neglected aspects of India's snakebite problem.
Rashmi U; Khochare S; Attarde S; Laxme RRS; Suranse V; Martin G; Sunagar K
J Proteomics; 2021 Jun; 242():104256. PubMed ID: 33957314
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of phosphorylation of rat synaptosomal proteins by snake venom phospholipase A2 neurotoxins (beta-bungarotoxin, notexin) and enzymes (Naja naja atra, Naja nigricollis).
Ueno E; Rosenberg P
Toxicon; 1990; 28(12):1423-37. PubMed ID: 2089738
[TBL] [Abstract][Full Text] [Related]
25. Proteomics analysis to compare the venom composition between Naja naja and Naja kaouthia from the same geographical location of eastern India: Correlation with pathophysiology of envenomation and immunological cross-reactivity towards commercial polyantivenom.
Chanda A; Patra A; Kalita B; Mukherjee AK
Expert Rev Proteomics; 2018 Nov; 15(11):949-961. PubMed ID: 30345852
[TBL] [Abstract][Full Text] [Related]
26. Species-specific and geographical variation in venom composition of two major cobras in Indian subcontinent: Impact on polyvalent antivenom therapy.
Mukherjee AK
Toxicon; 2020 Dec; 188():150-158. PubMed ID: 33127373
[TBL] [Abstract][Full Text] [Related]
27. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
[TBL] [Abstract][Full Text] [Related]
28. Gold Nanoparticles (AuNPs) Conjugated with Andrographolide Ameliorated Viper (
Ghosh S; Dasgupta SC; Dasgupta AK; Gomes A; Gomes A
J Nanosci Nanotechnol; 2020 Jun; 20(6):3404-3414. PubMed ID: 31748033
[TBL] [Abstract][Full Text] [Related]
29. Protective activity of medicinal plants and their isolated compounds against the toxic effects from the venom of Naja (cobra) species.
Shabbir A; Shahzad M; Masci P; Gobe GC
J Ethnopharmacol; 2014 Nov; 157():222-7. PubMed ID: 25291011
[TBL] [Abstract][Full Text] [Related]
30. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T
Front Immunol; 2023; 14():1175535. PubMed ID: 37283735
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization, biological activities and molecular docking of Epilobium parviflorum aqueous extract loaded chitosan nanoparticles.
Egil AC; Ozdemir B; Gok B; Kecel-Gunduz S; Budama-Kilinc Y
Int J Biol Macromol; 2020 Oct; 161():947-957. PubMed ID: 32544580
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the merit of the methanolic extract of
Nayak AG; Kumar N; Shenoy S; Roche M
3 Biotech; 2021 May; 11(5):228. PubMed ID: 33959471
[TBL] [Abstract][Full Text] [Related]
33. Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy.
Senji Laxme RR; Attarde S; Khochare S; Suranse V; Martin G; Casewell NR; Whitaker R; Sunagar K
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009150. PubMed ID: 33600405
[TBL] [Abstract][Full Text] [Related]
34. Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera.
Machiah DK; Gowda TV
Biochimie; 2006 Jun; 88(6):701-10. PubMed ID: 16494989
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of phytosynthesised silver nanoparticles from leaf extracts of
Elumalai D; Hemavathi M; Deepaa CV; Kaleena PK
Parasite Epidemiol Control; 2017 Nov; 2(4):15-26. PubMed ID: 29774292
[TBL] [Abstract][Full Text] [Related]
36. A Neurotoxic Snake Venom without Phospholipase A
Wong KY; Tan KY; Tan NH; Tan CH
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466660
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
38. Impact of
Williams HF; Hayter P; Ravishankar D; Baines A; Layfield HJ; Croucher L; Wark C; Bicknell AB; Trim S; Vaiyapuri S
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30558289
[TBL] [Abstract][Full Text] [Related]
39. Venomics of Naja sputatrix, the Javan spitting cobra: A short neurotoxin-driven venom needing improved antivenom neutralization.
Tan NH; Wong KY; Tan CH
J Proteomics; 2017 Mar; 157():18-32. PubMed ID: 28159706
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial activity of an acidic phospholipase A2 (NN-XIb-PLA2) from the venom of Naja naja (Indian cobra).
Sudarshan S; Dhananjaya BL
Springerplus; 2016; 5():112. PubMed ID: 26885465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
